Pharming PHAR Institutional Ownership

Pharming Group N.V. (NASDAQ:PHAR) is held by 18 institutional investors per 13F filings through June 2026.

• They owned 3.3% of outstanding stock in June 2026, up from 0.1% the prior quarter.
• Their total shares held in PHAR increased 2602.68% quarter over quarter, and separately, investors owning Pharming increased 350.0% from a year ago.
• Of these 18 holders, 12 added to their stakes in Pharming, 5 trimmed positions, and 1 made no changes.
• The aggregate institutional position in Pharming amounted to 2.24Mn shares as of June 2026, up by 2.16Mn shares quarter on quarter, and up 2.19Mn shares year over year.
• MAC Alpha Capital Management, LP holds the largest position in PHAR at 2.15Mn shares as of June 30, 2026, or 3.12% of shares outstanding.
• The biggest buyers of Pharming for the quarter ending June 2026 included MAC Alpha Capital Management, LP (2.15Mn), Crossmark Global Holdings, Inc. (12.46K), CITADEL ADVISORS LLC (1.78K), Silver Grove Financial Group, Inc. (1.07K), Global Retirement Partners, LLC (456).
• The largest sales of PHAR for the quarter ending June 2026 came from Silverberg Bernstein Capital Management LLC (3.2K), SmartHarvest Portfolios, LLC (382), Larson Financial Group LLC (336), OSAIC HOLDINGS, INC. (112), BNP PARIBAS FINANCIAL MARKETS (100).
• Business Quant data shows the 10 biggest positions in Pharming as of June 2026 are held by MAC Alpha Capital Management, LP (2.15Mn), Silverberg Bernstein Capital Management LLC (41.55K), Crossmark Global Holdings, Inc. (12.46K), CITADEL ADVISORS LLC (11.97K), Morgan Stanley (11.5K), SmartHarvest Portfolios, LLC (10.42K), Knoll Capital Management, LLC (4.09K), Silver Grove Financial Group, Inc. (1.07K), Nalls Sherbakoff Group, LLC (870), Global Retirement Partners, LLC (456).